ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

AstraZeneca to supply Japan with 120m COVID-19 vaccine doses

Tokyo's second deal, after Pfizer agreement, diversifies early-stage supply

AstraZeneca aims to bring its coronavirus vaccine on the market in September, with shipments to Japan starting early next year.   © Reuters

TOKYO -- AstraZeneca will provide 120 million doses of a coronavirus vaccine now in development to Japan under a basic agreement announced Friday by the Japanese government.

Shipments are slated to begin in early 2021, with Japan receiving 30 million doses by March, Health Minister Katsunobu Kato said.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more